Cagrilintide

Cagrilintide is a modified amylin analogue studied at amylin and calcitonin receptors. Its peptide structure includes a lipid modification, and published discovery research examined how that modification influenced receptor activity and albumin interaction.

Research context

An amylin receptor is a receptor complex: the calcitonin receptor associates with a receptor activity-modifying protein, abbreviated RAMP. Different RAMP partners create distinct amylin receptor subtypes. This makes the receptor’s composition an important part of describing an experiment.

Primary pharmacology research compared cagrilintide across receptor binding, activation and regulation measurements. The work shows why a single readout cannot fully describe a peptide’s receptor profile. Comparing the receptor subtype and the measured response provides a more useful account of its molecular behavior.

Lipid modification is a recurring strategy in peptide research because an attached fatty-acid chain can change how a peptide interacts with albumin and other proteins in solution. Studying how that modification alters receptor binding, activation and regulation helps researchers connect a defined chemical change with its measurable pharmacological consequences in cell-based systems.

Quality, Purity and Documentation

Review the analytical documentation listed for the selected size. Reports describe the samples identified in them; they do not by themselves confirm that current stock matches those samples. If no matching report is listed, contact Prestige Peptides for documentation before ordering.

Planned format

Cagrilintide 10mg is planned as a lyophilized (freeze-dried) powder in a sealed 10mg vial. Lyophilization removes water under vacuum at low temperature, producing a dry preparation suited to controlled laboratory storage. This listing is pending release; the notification form on this page registers interest for availability updates.

Storage and handling

Store lyophilized vials at -20°C or below, protected from light and moisture. Allow sealed vials to equilibrate to room temperature before opening to limit condensation inside the vial. Once opened, handle with clean laboratory technique, minimize exposure to ambient humidity, reseal promptly, and record the lot number in laboratory documentation for traceability.

For qualified in-vitro laboratory research only. Not for human or animal use.